KOCAA
IONS icon

Knights of Columbus Asset Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,381
Closed -$442K – 402
2019
Q3 		$442K Sell
7,381
-3,399
-32% -$222K 0.17% 113
2019
Q2 		$693K Buy
+10,780
New +$762K 0.27% 100

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Knights of Columbus Asset Advisors's IONS Position: Q4 2019 in Review

Knights of Columbus Asset Advisors sold out of Ionis Pharmaceuticals (IONS) in Q4 2019, closing a stake of 7,381 shares — an estimated $442K sold.

Knights of Columbus Asset Advisors first reported a position in IONS in Q2 2019 and held it in 2 quarters. The position peaked at $693K in Q2 2019. 391 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

  • Knights of Columbus Asset Advisors reported no remaining Ionis Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 7,381 Ionis Pharmaceuticals shares in Q4 2019, an estimated $442K.
  • Knights of Columbus Asset Advisors first reported a position in Ionis Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Knights of Columbus Asset Advisors's Ionis Pharmaceuticals position peaked at $693K in Q2 2019.
  • 391 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Knights of Columbus Asset Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.